It's important to enhance MG treatment outcomes with strong provider-patient relationships and ongoing monitoring, explain Ratna Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD. There is a critical need ...
Myasthenia gravis is a rare disease where the immune system attacks the communication between nerves and muscles, causing weakness. It often affects the muscles used for eye movement, facial ...
Regeneron's revenue in the second quarter increased by 4% year over year to $3.68 billion. That's not phenomenal top-line growth, but it's pretty strong considering Eylea's challenges. Furthermore, ...
McGill University researchers have engineered a new hydrogel that shows early promise as a treatment for people with vocal ...
Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring ...
A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
SOUTH BEND, IN (WSBT) — A new mural is bringing hope to downtown South Bend. Life Treatment Centers unveiled the new artwork at a dedication on Monday. It now spans the front of their building on ...
Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire network of RNA-protein interactions inside human cells—an achievement that could ...
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...
NEW MEXICO (KRQE) – There is a lack of drug treatment centers in the state of New Mexico, largely caused by the shutdown in 2013 and difficulty finding staff. Treatment centers like the Santa Fe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback